Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-09 Sale |
2021-03-11 4:30 pm |
SpringWorks Therapeutics Inc. | SWTX | Bain Capital Life Sciences Investors LLC BC SW LP Schwartz Jeffrey Lawrence Koppel Adam 10% Owner |
1,450,000 | $71.5 | $103,675,000 | 5,831,307 (Indirect) |
View |
| 2021-03-01 Sale |
2021-03-03 6:55 pm |
SpringWorks Therapeutics Inc. | SWTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC 10% Owner |
1,220,000 | $83.19 | $101,491,800 | 6,186,307 (Indirect) |
View |
| 2021-01-25 Sale |
2021-01-26 4:31 pm |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
32,000 | $84.07 | $2,690,282 | 261,542 (Direct) |
View |
| 2021-01-20 Sale |
2021-01-21 4:31 pm |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $78.7 | $787,016 | 283,258 (Direct) |
View |
| 2021-01-19 Sale |
2021-01-21 4:30 pm |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
62,500 | $78.55 | $4,909,390 | 1,222,997 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-04-01 Option Award |
2021-04-01 5:37 pm |
N/A 2031-04-01 |
SpringWorks Therapeutics Inc. | SWTX | Ashar Bhavesh Chief Commercial Officer |
104,500 | $0 | 104,500 (Direct) |
View |
| 2020-12-08 Ownership |
2021-02-11 4:30 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director |
100,000 | $0 | 459,577 (Direct) |
View |
| 2021-01-20 Exercise |
2021-01-21 4:31 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
8,872 | $2.3 | 283,258 (Direct) |
View |
| 2021-01-20 Exercise |
2021-01-21 4:31 pm |
N/A 2029-03-19 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
10,000 | $0 | 283,258 (Direct) |
View |
| 2021-01-20 Exercise |
2021-01-21 4:31 pm |
N/A N/A |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
1,128 | $1.65 | 283,258 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-11 09:31 am |
N/A 2031-01-07 |
SpringWorks Therapeutics Inc. | SWTX | Weinstein Herschel S General Counsel and Secretary |
63,000 | $0 | 63,000 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-11 09:30 am |
N/A 2031-01-07 |
SpringWorks Therapeutics Inc. | SWTX | Smith L. Mary Chief Development Officer |
99,000 | $0 | 255,511 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-11 09:30 am |
N/A 2031-01-07 |
SpringWorks Therapeutics Inc. | SWTX | Renstrup Jens Chief Medical Officer |
54,675 | $0 | 299,099 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-11 09:30 am |
N/A 2031-01-07 |
SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer |
37,350 | $0 | 37,350 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-11 09:30 am |
N/A 2031-01-07 |
SpringWorks Therapeutics Inc. | SWTX | Francis Perier I Jr Chief Financial Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-11 09:29 am |
N/A 2031-01-07 |
SpringWorks Therapeutics Inc. | SWTX | Nofi Michael Chief Accounting Officer |
27,000 | $0 | 27,000 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-11 09:28 am |
N/A 2031-01-07 |
SpringWorks Therapeutics Inc. | SWTX | Islam Saqib Chief Executive Officer |
337,500 | $0 | 1,585,497 (Direct) |
View |
| 2021-01-07 Option Award |
2021-01-11 09:28 am |
N/A 2031-01-07 |
SpringWorks Therapeutics Inc. | SWTX | Edris Badreddin Chief Operating Officer |
117,000 | $0 | 397,542 (Direct) |
View |
| 2020-08-03 Option Award |
2020-08-05 6:08 pm |
N/A 2030-08-03 |
SpringWorks Therapeutics Inc. | SWTX | Pichl Daniel Chief People Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:38 pm |
N/A 2030-05-20 |
SpringWorks Therapeutics Inc. | SWTX | Fuhrman Alan Director |
7,464 | $0 | 7,464 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:38 pm |
N/A 2030-05-20 |
SpringWorks Therapeutics Inc. | SWTX | SQUINTO STEPHEN P Director 10% Owner |
7,464 | $0 | 7,464 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:37 pm |
N/A 2030-05-20 |
SpringWorks Therapeutics Inc. | SWTX | LYNCH DANIEL Director 10% Owner |
7,464 | $0 | 7,464 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:37 pm |
N/A 2030-05-20 |
SpringWorks Therapeutics Inc. | SWTX | Lewis-Hall Freda C Director 10% Owner |
7,464 | $0 | 7,464 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:34 pm |
N/A 2030-05-20 |
SpringWorks Therapeutics Inc. | SWTX | Hambleton Julie Director |
14,668 | $0 | 14,668 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:16 pm |
N/A 2030-05-20 |
SpringWorks Therapeutics Inc. | SWTX | Schwartz Jeffrey Lawrence Director 10% Owner |
7,464 | $0 | 7,464 (Direct) |
View |